GoodRx (GDRX) Revenue & Revenue Breakdown
GoodRx Revenue Highlights
Latest Revenue (Y)
$750.26M
Latest Revenue (Q)
$200.61M
Main Segment (Y)
Prescription Transactions Revenue
GoodRx Revenue by Period
GoodRx Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $750.26M | -2.12% |
2022-12-31 | $766.55M | 2.83% |
2021-12-31 | $745.42M | 35.36% |
2020-12-31 | $550.70M | 41.85% |
2019-12-31 | $388.22M | 55.59% |
2018-12-31 | $249.52M | - |
GoodRx Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $200.61M | 1.38% |
2024-03-31 | $197.88M | 0.63% |
2023-12-31 | $196.64M | 9.27% |
2023-09-30 | $179.96M | -5.12% |
2023-06-30 | $189.68M | 3.09% |
2023-03-31 | $183.99M | -0.07% |
2022-12-31 | $184.11M | -1.71% |
2022-09-30 | $187.32M | -2.34% |
2022-06-30 | $191.80M | -5.67% |
2022-03-31 | $203.33M | -4.65% |
2021-12-31 | $213.26M | 9.30% |
2021-09-30 | $195.10M | 10.45% |
2021-06-30 | $176.63M | 10.10% |
2021-03-31 | $160.43M | 4.49% |
2020-12-31 | $153.54M | 9.32% |
2020-09-30 | $140.45M | 13.92% |
2020-06-30 | $123.30M | -7.58% |
2020-03-31 | $133.41M | 17.79% |
2019-12-31 | $113.26M | 11.31% |
2019-09-30 | $101.75M | 11.16% |
2019-06-30 | $91.53M | 5.68% |
2019-03-31 | $86.61M | - |
GoodRx Revenue Breakdown
GoodRx Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|---|
Other Revenue | $20.05M | $20.43M | $92.14M | $62.44M |
Subscription Revenue | $94.41M | $96.17M | $59.92M | - |
Prescription Transactions Revenue | $550.74M | $550.54M | $593.36M | $488.26M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Revenue | $5.39M | $5.38M | $5.23M | $5.39M | $4.93M | $4.50M | $5.17M | $5.15M | $4.86M | $5.24M | $37.09M | $23.22M | $17.46M | $26.37M | $22.24M | $16.07M |
Prescription Transactions Revenue | $140.42M | $145.40M | $143.86M | $135.43M | $136.54M | $134.91M | $129.41M | $131.22M | $134.40M | $155.51M | $158.79M | $155.65M | $144.86M | $134.06M | $131.31M | $124.39M |
Subscription Revenue | $21.31M | $22.60M | $23.15M | $23.24M | $23.88M | $24.14M | $24.62M | $26.45M | $25.98M | $19.11M | $17.38M | $16.23M | $14.32M | - | - | - |
Pharma Manufacturer Solutions Revenues | - | - | - | - | $24.33M | $20.43M | $24.50M | $26.55M | $23.47M | - | - | - | - | - | - | - |
Latest
GoodRx Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
GEHC | GE HealthCare | $19.55B | $4.86B |
TDOC | Teladoc Health | $2.60B | $640.51M |
VEEV | Veeva Systems | $2.36B | $699.21M |
EVH | Evolent Health | $1.96B | $621.40M |
PRVA | Privia Health Group | $1.66B | $422.33M |
PGNY | Progyny | $1.09B | $286.63M |
GDRX | GoodRx | $750.26M | $200.61M |
TXG | 10x Genomics | $618.73M | $151.65M |
DOCS | Doximity | $475.42M | $136.83M |
ACCD | Accolade | $414.29M | $106.36M |
CERT | Certara | $354.34M | $94.82M |
HCAT | Health Catalyst | $295.94M | $76.35M |
HSTM | HealthStream | $279.06M | $73.09M |
DH | Definitive Healthcare | $251.41M | $62.70M |
SDGR | Schrödinger | $216.67M | $47.33M |
TALK | Talkspace | $150.04M | $138.84M |
NRC | National Research | $148.58M | $35.82M |
SLP | Simulations Plus | $70.01M | $18.54M |
AMWL | American Well | - | - |